CoChat

Tryptophan‐2,3‐dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor‐4

Open access
Ochs, Katharina, Ott, Martina, Rauschenbach, Katharina J., Deumelandt, Katrin, Sahm, Felix, Opitz, Christiane A., von Deimling, Andreas, Wick, Wolfgang, Platten, Michael · 2016 · Journal of Neurochemistry
Cited by 54

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Malignant gliomas and other types of tumors generate a local immunosuppressive microenvironment, which prohibits an effective anti‐tumor immune response and promotes tumor growth. Along with others, we have recently demonstrated that catabolism of the essential amino acid tryptophan via tryptophan‐2,3‐dioxygenase (TDO) is an important mechanism mediating tumor‐associated immunosuppression particularly in gliomas. The pathways regulating TDO in tumors, however, are poorly understood. Here, we show that prostaglandins enhance TDO expression and enzymatic activity in malignant gliomas via activation of prostaglandin E receptor‐4 (EP 4). Stimulation with prostaglandin E 2 (PGE2) up‐regulated TDO‐mediated kynurenine release in human glioma cell lines, whereas knockdown of the PGE2 receptor EP 4 inhibited TDO expression and activity. In human malignant glioma tissue expression of the PGE2‐producing enzyme cyclooxygenase‐2 (COX 2) and its receptor EP 4 were associated with TDO expression both on transcript and protein level. High expression of EP 4 correlated with poor survival in malignant glioma patients WHO III‐IV. Importantly, treatment of glioma cells with an EP 4 inhibitor decreased TDO expression and activity. Moreover, TDO‐over‐expressing murine gliomas showed increased COX 2 and EP 4 expression suggesting a positive feedback mechanism in vivo. In summary, targeting EP 4 may inhibit – in addition to immunosuppressive COX 2 signaling – tryptophan degradation as another important immunosuppressive pathway and thus, could provide a dual clinically relevant immunotherapeutic avenue for the treatment of malignant gliomas. image We proposed that in malignant gliomas prostaglandin E 2 (PGE 2) produced by cyclooxygenases (COX) up‐regulates tryptophan‐2,3‐dioxygenase (TDO) expression and enzyme activity through binding to its Gs‐coupled receptor EP4 and therefore may mediate tumor immune escape in part through aryl hydrocarbon receptor (AHR) activation. Moreover, TDO activity itself seems to induce intratumoral PGE 2 metabolism suggesting an immunosuppressive loop involving COX/EP4/TDO.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jnc.13503

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 54

Metadata

Authors
Ochs, K., Ott, M., Rauschenbach, K. J., Deumelandt, K., Sahm, F., Opitz, C. A., von Deimling, A., Wick, W., & Platten, M.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2016-01-22
Volume
136
Issue
6
Pages
1142-1154
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2197798862
Cited by
54
References
4
FWCI
0.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tryptophan‐2,3‐dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor‐4. https://app.cochat.ai/papers/10.1111/jnc.13503
The paper
Ochs, K., Ott, M., Rauschenbach, K. J., Deumelandt, K., Sahm, F., Opitz, C. A., von Deimling, A., Wick, W., & Platten, M. (2016). Tryptophan‐2,3‐dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor‐4. Journal of Neurochemistry. https://doi.org/10.1111/jnc.13503

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.